Pharmaceutical manufacturing Related Topics 
European Pharmaceutical Review
APRIL 10, 2025
This poses a significant challenge for pharmaceutical manufacturers, not least because of the technical challenges related to operations, supply chain and the environment. This article explores the potential impact of the proposal and considers how manufacturers can ensure the safety and reliability of their products.
European Pharmaceutical Review
JANUARY 9, 2024
Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. Integrative Analysis of Multi-Omics Data with Deep Learning: Challenges and Opportunities in Bioinformatics.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
SEPTEMBER 28, 2023
According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), more than 600 essential medicines are at risk if a proposed restriction on the use of fluorinated substances, per- and polyfluoroalkyl substances (PFAS) across pharmaceutical manufacturing in the EEA, is implemented.
European Pharmaceutical Review
JULY 15, 2022
Large energy users such as pharmaceutical manufacturers can play an important role in protecting grid stability while enabling more renewable generation. By adopting a sustainable energy strategy, pharmaceutical manufacturers can reduce carbon emissions, help maintain the stability of the grid and create valuable sources of new income.
European Pharmaceutical Review
JULY 9, 2024
In conclusion, because there is “so little nitrite in purified water” using it in drug substance manufacturing processes, “even under acidic conditions and in the presence of vulnerable amines, does not constitute a nitrosamine presence risk for the product in most cases”. The paper was published in Organic Process Research & Development.
PharmaTech
JANUARY 17, 2025
Pharmaceutical Technology spoke with Charles Ruban, president and CEO, Verdot, about the focus of moving to sustainability practices in pharmaceutical manufacturing.
MedCity News
AUGUST 16, 2022
This “operational technology” (OT) is critical for pharmaceutical manufacturing and R&D organizations. Today’s factory floors include production equipment that’s linked directly into those IT systems that are so often the victims of a cyberattack.
Expert insights. Personalized for you.
59 
Let's personalize your content